This is the second of four articles discussing the evaluation of diagnostic studies for podiatric physicians. This article deals with the evaluation of internal and external validity of a diagnostic study. Diagnostic articles from the foot/ankle literature will be used to illustrate the concepts of critical analysis.
Internal validity
The Consort statement is a set of published guidelines for the reporting of randomized controlled trials in the medical literature. 2 The diagnostic counterpart to this document is the STARD Statement*. 3 Most of the major medical journals with high impact factors have adopted these guidelines as requirements for publication. In the first article of this series 1 it was stated that the best study design for a diagnostic test was a cross sectional study of an independent, masked comparison with a reference standard among an appropriate population of consecutive patients. If properly planned and reported this type of study can be considered level I evidence for studies of diagnostic accuracy. The reader is referred to the following reference for a more complete explanation of the various study designs and levels of evidence for diagnostic studies.
Was there an appropriate consecutive population of patients enrolled in the study?
It is unacceptable to only enroll patients with severe symptoms and signs of the target disease to be compared to disease free people who are healthy asymptomatic volunteers. Studies 5, 6 which use obvious diseased individuals compared with normal individuals do not provide any useful diagnostic information. Large overestimation of diagnostic accuracy has been shown when studies enroll only patients with advanced symptoms compared to normal controls. 7, 8 The sensitivity and specificity of a test depends on the characteristics of the population studied. There needs to be a spectrum of patients similar to the patients we would use the test on in normal clinical practice. The spectrum should contain patients exhibiting mild signs and symptoms who are early in the target disease to late severe patients with the target disease as well as, conditions commonly confused with the target disease. Failure to enroll an appropriate population of patients results in spectrum bias with an overestimation of diagnostic effect. Readers of diagnostic studies should look for a description of the study population to include: definition of the target population, study location, age distribution, sex distribution, summary of presenting clinical symptoms and/or disease stage when evaluating diagnostic studies for spectrum bias.
Ideally patients will be prospectively enrolled in the study consecutively based upon suspicion of clinically having the target disease. It is important for the reader to review the method by which the patients entered the study. Alternate study designs may produce spectrum bias affecting the results of the study. One study showed 8 that accuracy of the index test was lower in studies that selected patients on the basis of whether they had been referred for the index test rather than on clinical symptoms. Failure to enroll patients consecutively (selection bias) and retrospective studies 9 are associated with an overestimation of diagnostic accuracy. In the first article of this series 1 it was proposed that post-test probabilities and predictive values vary with target disease prevalence. In contrast, sensitivities, specificities and likelihood ratios do not. 10 LRs are affected by disease spectrum. As long as the disease spectrum is the same prevalence will not affect LR, sensitivity or specificity. Studies with a different spectrum of disease will result in different LRs. In general, infected diabetic ulcers are less common and less severe with more subtle changes when seen in a podiatric physician's office setting than in patients with diabetic infected ulcers referred to a tertiary care center. Evaluating the spectrum of patients making up the study is a key and critical decision in judging the validity of diagnostic studies.
The two studies which we will use in this article to illustrate the critical analysis of diagnostic tests both evaluate the usefulness of a probe to bone test for osteomyelitis in diabetic infected ulcerations of the feet. 11, 12 Both studies evaluated infected diabetic foot ulcers for osteomyelitis using a metal probe of the wound to detect bone. A positive probe to bone test is thought to aid in the diagnosis of osteomyelitis. Ideally a consecutive series of patients with clinical findings of the target disease are subject to the index test and then verified by the reference standard. The term reference standard is sometimes referred to as the gold standard. Ideally a reference/gold standard should be able to distinguish between all normal people and people with the target disease. This test would be 100% sensitive and 100% specific with no false-positives or false-negative results. It is unlikely that any test will perform this well. Some common examples of appropriate reference standards are: biopsy, autopsy or long-term follow-up without treatment. While the choice of a reference standard may not be perfect it is essential for the reader of the study to have confidence in the reference standard used to identify the target disorder. It is important that the results of the index test not be part of the decision to perform the reference standard. In addition, there should be a close temporal relationship between the performance of the index test and the reference standard. Failure to perform the tests in an appropriate time sequence may result in an intervention in the care of the patient which would alter results of the reference standard and therefore bias the results.
Grayson
Grayson, et. al., 11 chose bone biopsy with histologic determination as the reference standard. Not all patients had a bone biopsy in some cases the reference standard included radiographic changes, clinical identification the bone by a surgeon during surgical debridement and after a short course of antibiotics if the ulceration resolved and did not recur. The authors report that the results of the index test influenced the decision to biopsy the bone. The intervals between the evaluation of the ulcer and biopsy of the bone for evaluation averaged 13.9 days (5-42). Lavery, et al., 12 also used a bone biopsy as a reference standard however; the authors relied on culture results rather than histologic examination. The authors clearly described that the decision to biopsy the bone was not influenced by the results of the index test.
It wasn't clearly stated what the time difference was between the performance of the index test and the reference standard. In addition, patients that did not receive a bone biopsy were followed for resolution of the ulcer without complications.
Was the selected reference standard used for all of the patients receiving the index test?
It is essential that all of the patients who received the index test also receive the same reference standard. It has been shown 7, 8 that using different reference standards for positive and negative index tests results, produces an overestimation of diagnostic tests effectiveness. The terms verification bias or workup bias are used to describe the process of using different referenced standards.
Grayson, et. al., 11 enrolled 75 patients with 76 ulcers. Bone was biopsied in 53 patients 46 of which demonstrated histological changes associated with osteomyelitis. Four patients were not biopsied but osteomyelitis was diagnosed clinically by means of radiographs, and/or evaluation the bone clinically by the surgeon during debridement. Nineteen cases were excluded from a diagnosis of osteomyelitis because of clinical follow-up. Lavery, et. al., 12 biopsied 30 patients of the 247 patients enrolled in the study. It appears the majority of patients were followed forward in time until the wound healed or they required surgical therapy.
Were the investigators evaluating the index test and the reference standard blinded to the results?
Knowledge of the index test can bias the interpretation of the reference standard. This is termed review bias. The index test and reference standard should be independently evaluated. Although intuitively this makes sense and one would expect that the diagnostic results would be affected by lack of blinding, this has not been shown to alter the diagnostic results in two large studies. 7, 8 The authors of these studies suggest that if the reference standard was subjective this effect would be greater. Grayson, et. al., 11 clearly stated in their article that the pathologist evaluating the bone biopsy was not aware of the results of the probe to bone test. It is not clear if the physicians interpreting the radiographs, debriding the wounds and following the patients were blinded to results from the probe to bone test. Lavery, et al., 12 did not state during the methods section if anyone was blinded in the study. The podiatrists who performed the probe to bone test followed the patients who were not biopsied to evaluate their clinical status.
Was there a sample size calculation?
While it is common for randomized controlled trials to report calculations for sample size similar explanations are usually not found when reviewing diagnostic studies. Failure to calculate sample size estimates prior to beginning the study results in studies which may be too small to provide precise estimates of sensitivity and specificity. A method of how to perform sample size calculations for diagnostic studies has been advanced by Carly, et. al. 14 Neither probe to bone study 11, 12 described a sample size calculation for sensitivity and specificity. Although, neither article reported results in terms of likelihood ratios, using the information in the article point estimates with 95% confidence intervals can be calculated for LRs 15 ( Table 1) . LRs can be categorized from having a minimal to a large effect on pretest probabilities.
16 (Table 2) The results for a +LR calculated from Grayson, et. al.,'s study 11 reveals a point estimate for a +LR to be 4.29 indicating a small effect.
However, using the results of the 95% confidence interval the true effect lies between 1.7 and 11 or from a minimal effect to a large conclusive effect. The range of the 95% confidence interval reveals that there is a lack of precision with this measurement likely due to the number of patients enrolled in the study. Similarly in Lavery, et. al.,'s study 12 the point estimate for the -LR is 0.15 indicating a moderate effect. However, the results of the 95% confidence interval indicate the true value could lie anywhere between 0.06 a large conclusive effect to 0.37 consistent with a small effect. Again, this indicates that too few patients were enrolled in the study to allow for accurate estimate of the diagnostic effect.
External validity

Did the authors provide information regarding evaluating and limiting variability of the index test and reference standard?
The authors of the study should clearly describe the index test used in the study to allow for replication by the reader. Failure to do this has been shown to introduce bias into the study. 7 Intraobserver and interobserver variability occurs when interpreting diagnostic tests. Experts may not agree upon the interpretation of radiographs and instruments may need to be calibrated. Differences in test interpretation may bias the results of the study in a systematic manner. The authors should describe the efforts which were made to standardize the evaluation of the index test used in the study. This may include the use of statistical measures to evaluate agreement among experts.
After reviewing the description of index test in the article the reader will need to decide whether or not the test will be reproducible in his or her practice setting. In order to implement the index test it may be necessary for additional costs, training regarding the performance and interpretation of the test.
The authors of the probe to bone studies 11, 12 described in sufficient detail the index test used in the study.
Neither provided any information regarding statistical measures to evaluate agreement among experts. It does not seem that any special training, cost or education would be necessary to implement the index test in an average podiatric physician's office.
Are the patients in the study similar enough to my patients?
The LR of an index test should vary with the spectrum of the patients enrolled in the study. 17 Podiatric physicians will need to consider if their practice setting is similar to the article and whether their patient under consideration would have been included in the study.
Clearly the spectrum of disease is different in the two studies evaluating the probe to bone test for osteomyelitis.
11,12 Grayson's study 11 was performed in severe limb-threatening infections at a tertiary care hospital. In contrast, Lavery, et. al.,'s study 12 was performed on a less severe population of diabetic patients in an out-patient setting. Since the majority of podiatric physicians will encounter infected diabetic ulcers in an outpatient setting rather than a tertiary care institution the results of Lavery, et. al.,'s study are more relevant for the majority of podiatric physicians.
Will the results of the study change my diagnostic approach?
In order to use likelihood ratios derived from a diagnostic study the podiatric physician should have some idea of the pretest probability of the target disorder in their patient population. This can be accomplished by reviewing the published literature on the subject, using the pretest probabilities in the diagnostic study, personal experience and clinical judgment. If the podiatric physician cannot determine pretest probability of the target disease it is unlikely the results of the study will provide any meaningful information. Podiatric physicians are likely to have some process by which they arrive at a diagnosis for common conditions. This may include elements of the history and physical examination in conjunction with diagnostic studies. How should the index test be incorporated into the podiatric physician's diagnostic process? Should the index test serve as a replacement for an existing test or an addition to the normal diagnostic process? Will the results of the diagnostic test change the test/treatment threshold? If the answer to this question is no then the podiatric physician needs to recognize that additional testing will be necessary in order to pass the test/treatment threshold. (Fig 1) Grayson's study 11 demonstrated a prevalence of 66% which was associated with a + LR of 4.4 and a -LR of 0.4. (Table1) The posttest probability with a +LR was 90% and the posttest probability with a -LR was 44%. (Table 3 ) This should be interpreted that a positive test is above the treatment threshold while a negative result lies within an intermediate range indicating further testing is necessary. (Fig 1) To evaluate the precision of these results we need to consider the 95% confidence intervals about the LR point estimate. The values of the 95% confidence interval for a -LR remained within the intermediate range indicating further diagnostic studies are necessary however, the lower boundary of a +LR is only 77%. The reader will need to decide if a worst-case scenario for a positive test (77% posttest probability) is above the treatment threshold.
Lavery, et. al.,'s study
12 demonstrated a prevalence of 12% which was associated with a +LR of 9.4 and a -LR of 0.15. (Table 1) The posttest probability with a -LR was 2% while the posttest probability of a +LR was 56%. (Table 3) A positive result falls within in the intermediate range of posttest probabilities indicating that further diagnostic studies are necessary and a negative result falls below the test threshold. (Fig 1) When the values of the 95% confidence intervals are considered about the posttest probabilities it is clear that a positive test still remains within the intermediate range indicating further diagnostic studies are necessary and the 95% confidence intervals for negative test still remain below the test threshold indicating further diagnostic studies are unnecessary. The conclusion that the reader should reach is that a negative probe to bone test in severe diabetic infected ulcers at a tertiary care center and a positive probe to bone test in a less severe diabetic infected ulcer in outpatient primary care setting require additional testing and a negative probe to bone test in an infected diabetic ulcer in a primary care outpatient setting does not require additional testing. A positive probe to bone test in a severely infected diabetic foot ulcer at a tertiary care center may not be definitive for osteomyelitis.
Multiple diagnostic tests may be utilized in two different ways. 18 They may be used in a parallel fashion or a serial fashion. Parallel testing is usually performed in an emergency room or hospital setting when rapid assessment of disease processes are necessary. Typically there will be an increase in sensitivity but a decrease in specificity resulting in higher false positives. This is most useful when the podiatric physician is faced with multiple diagnostic tests of low sensitivity. Serial testing is the process whereby diagnostic tests are ordered one at a time and are dependent upon the results of the previous test. Typically this process is used in outpatient settings where there is not an urgent need to make a diagnosis. This process is useful when the diagnostic studies are expensive or risky.
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